Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System
- 2020年10月09日 18:00:00
- テクノロジー
- JCN Newswire
- コメント
As a global leader in designing and delivering innovative solutions for medical and surgical procedures, Olympus aims to improve the health and quality of life of patients by providing advanced medical technologies. Its latest endoscopy system, EVIS X1, was developed to set new standards for image detection, characterization, staging, and treatment. With the newly introduced endoscopy CAD (computer-aided detection/diagnosis) platform ENDO-AID, Olympus is now enhancing the capabilities of EVIS X1 through AI technology, aiming to elevate the standard of endoscopy around the world - whether for applications to disorders of the esophagus, stomach, colon or other gastrointestinal organs.
ENDO-AID CADe: real-time computer-aided detection for endoscopy
ENDO-AID CADe is an application for computer-aided detection powered by AI which runs on ENDO-AID. It uses a complex algorithm via a neural network developed and trained by Olympus. With this new application, the system's sophisticated machine learning can alert the endoscopist in real time when a suspected colonic lesion (such as a polyp, malignant neoplasm or adenoma) appears on the screen.
ENDO-AID CADe was developed toward the following improvements:
- Improved observational performance in adenoma detection: By providing visual support, ENDO-AID CADe aims to improve the observational performance of the endoscopist's adenoma detection.
- Support of the colonoscopy screening process: The system provides visual support during screening, allowing the endoscopist to focus on any abnormalities indicated by the software regardless of the experience level of the endoscopist.
- Efficient endoscopy operation: Due to the simple and intuitive display of lesions, ENDO-AID CADe has the potential to make endoscopy easier and more efficient for the endoscopist by reducing the need for excessive eye movements.
A first step towards the future of endoscopic diagnosis and therapy
With ENDO-AID, the latest feature of the EVIS X1 endoscopy system, Olympus has created the basis and infrastructure for the installation of future applications supported by AI. "At Olympus we are committed to innovation and driving our research and development with passion,"says Frank Drewalowski, Head of Endoscopic Solutions Division, Olympus Corporation. "Especially in AI, we recognize the power of elevating endoscopic imaging to uncharted levels. Considering ENDO-AID as a first step, we are planning additional AI-powered applications for image detection and characterization - not only for colonoscopy."
Prevention of colorectal cancer remains our focus
There is a positive impact of an increase in adenoma detection rate (ADR) on the prevention of colorectal cancer (CRC)(2). Supporting the identification of lesions, ENDO-AID CADe is designed to increase ADR(3). We are aiming to increase the quality of CRC screening and its preventive efficacy against CRC. The prevention of CRC is a core element of Olympus'endeavors in medical endoscopy and beyond.
"With the launch of ENDO-AID, we are not only providing endoscopists across the world with an additional innovative tool,"says Takaharu Yamada, Vice President, GI Endoscopy Business Leader, Endoscopic Solutions Division. "We are also preparing for the future and following our vision of putting CRC in the history books."
Official launch at United European Gastroenterology Week (UEGW)
During the virtual UEGW from October 11 to 13, ENDO-AID will be presented to the public for the first time. ENDO-AID is initially and commercially being launched in Europe beginning in November, followed shortly afterwards by some Middle Eastern, African and Asian-Pacific countries. Japan, the Americas and China markets will follow at a later time after complying with laws and regulations in each region. EVIS X1 and ENDO-AID are manufactured by Olympus Medical Systems Corporation. The company and product names specified in this release are the trademarks or registered trademarks of Olympus.
(1) Product Name: Endoscopy CAD system
(2) Corley, D.A.;Jensen, C.D.;Marks, A.R.;et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. N Engl J Med. 2014;370: 1298-1306. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036494/. Accessed in October 2020
(3) Compared to WLI (white light imaging) without CADe
About Olympus
Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries, as well as cameras and audio products. For more than 100 years, Olympus has focused on making people's lives healthier, safer, and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, ensuring public safety, and capturing images of the world.
Olympus Endoscopic Solutions uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with the world's first gastrocamera in 1950, Olympus'endoscopic portfolio has grown to include endoscopes, laparoscopes, and video imaging systems, as well as systems integration solutions and medical services.
For questions or additional information, please contact:
Europe, Middle East and Africa
Matthias Gengenbach
+49 15142369420
matthias.gengenbach@olympus-europa.com
Japan
Yuka Horimoto
+81 90 2490 1071
yuka_horimoto@ot.olympus.co.jp
Asia Pacific
Oliver Clarke
+61 3 9271 5508
oliver.clarke@olympus.com.au
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
大谷翔平、パーフェクトな13号先頭打者アーチ 右翼席中段へ飛び込む飛距離130mの特大弾
中居正広氏側に助言の橋下徹氏、性暴力の解釈巡り「意に反すれば全てアウトでは後から言えば…」
空自機墜落事故 安否不明の2隊員の氏名公表
公取委、スマホ新法の取り締まり内容公表 12月に全面施行
【阪神】魔球「ナックル」操るニック・ネルソンが初昇格 捕手も困惑する不規則変化に注目
今田美桜、NHK朝ドラ「あんぱん」15・0% のぶは赤いハンドバッグを受け取らず…
山陽バス、急ブレーキで1歳児含む乗客7人搬送 神戸・垂水
ドジャースの超有望株ラッシング、グレーTシャツ&力強い眼差しで堂々のドジャースタジアム入場
女性芸人、動画配信者の迷惑行為に怒り「二度と話しかけるなよ」「普通に失礼な人」
TBSテレビとスクエニ、新たなゲームIPで協業 グローバル展開も視野に
「80歳に見えない」国民的女優、のんと2ショット「若い頃に似てる」「奇跡」圧倒的美貌に騒然
指原莉乃「実はすんごいことが起きまして」喜びの報告に「本当に凄い」「私まで嬉しい」祝福の声
解散した国民的男性アイドルグループ、元メンバーの2ショット写真に「こんな日がくるなんて」
空自機墜落事故 安否不明の2隊員の氏名公表
多部未華子(30)結婚の裏事情あまりにも恐ろしすぎると話題に!
「ハンサム胸」33歳女優が豪華ランジェリーショット公開「刺激強すぎ」「ま、まぶしい」絶賛の嵐
博多駅で痴漢疑われ…専門学生を殴った疑い 福岡市職員を逮捕
42歳女性芸人涙「怖い怖い怖い」浜田雅功代役MCオファー受け困惑→動揺「気持ち悪い」水ダウ
二階堂ふみが結婚!?お相手が衝撃的過ぎてネット民「マジか・・・」
ケンコバ、アインシュタイン稲田から“ブチギレ”され反省「よかれと思ってたことでも…」
二階堂ふみが結婚!?お相手が衝撃的過ぎてネット民「マジか・・・」
小澤征悦と再婚した桑子真帆アナ(34)黒い過去が流出、衝撃の過去にネット騒然
関ジャニ錦戸亮、登場人物が全員クズだらけの不倫劇もメディア沈黙で批判殺到
多部未華子(30)結婚の裏事情あまりにも恐ろしすぎると話題に!
中居正広氏側の反論から浮かんだ2つの新事実を指摘「性暴力の評価はともかく…」紀藤正樹弁護士
ガーシー、佐野ひなこの暴露を示唆でネット騒然「ファンだったのに」
「名探偵コナン」最大の謎、蘭姉ちゃんのあの角の正体がついに判明
中居正広氏側が反論しXトレンド「中居ヅラ」書き込み続々も「じゃあ何で引退?」激論
【おすすめアニメ50選】完結済み!定番から最新作まで!
性被害告白で話題の元女子アナユーチューバー「無事、クビに」契約解除を報告

大谷翔平、パーフェクトな13号先頭打者アーチ 右翼席中段へ飛び込む飛距離130mの特大弾
中居正広氏側に助言の橋下徹氏、性暴力の解釈巡り「意に反すれば全てアウトでは後から言えば…」
空自機墜落事故 安否不明の2隊員の氏名公表
公取委、スマホ新法の取り締まり内容公表 12月に全面施行
今田美桜、NHK朝ドラ「あんぱん」15・0% のぶは赤いハンドバッグを受け取らず…
【阪神】魔球「ナックル」操るニック・ネルソンが初昇格 捕手も困惑する不規則変化に注目
山陽バス、急ブレーキで1歳児含む乗客7人搬送 神戸・垂水
ドジャースの超有望株ラッシング、グレーTシャツ&力強い眼差しで堂々のドジャースタジアム入場
女性芸人、動画配信者の迷惑行為に怒り「二度と話しかけるなよ」「普通に失礼な人」
TBSテレビとスクエニ、新たなゲームIPで協業 グローバル展開も視野に